Overview of Targeted Drugs for Mature B-Cell Non-hodgkin Lymphomas

The improved knowledge of pathogenetic mechanisms underlying lymphomagenesis and the discovery of the critical role of tumor microenvironments have enabled the design of new drugs against cell targets and pathways. The Food and Drug Administration (FDA) has approved several monoclonal antibodies (mA...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Oncol
Autors principals: Crisci, Stefania, Di Francia, Raffaele, Mele, Sara, Vitale, Pasquale, Ronga, Giuseppina, De Filippi, Rosaria, Berretta, Massimiliano, Rossi, Paola, Pinto, Antonio
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2019
Matèries:
Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6558009/
https://ncbi.nlm.nih.gov/pubmed/31214498
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00443
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars